Latest debt-to-equity ratio
Scinai Immunotherapeutics Debt-to-equity ratio
Direct answer
Scinai Immunotherapeutics's debt-to-equity ratio is 30.52%.
The verified market snapshot reports 30.52%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free Scinai Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 30.52%
Explore related company data
View Scinai Immunotherapeutics's market capitalizationView Scinai Immunotherapeutics's p/e ratioView Scinai Immunotherapeutics's price-to-book ratioView Scinai Immunotherapeutics's return on equityView Scinai Immunotherapeutics's dividend yieldView Scinai Immunotherapeutics's 52-week price rangeView Scinai Immunotherapeutics's revenue growthView Scinai Immunotherapeutics's profit marginView all Scinai Immunotherapeutics key metricsReturn to Scinai Immunotherapeutics profile